APAC Tissue Diagnostics Market Size, Growth | 2022 to 2027 | India, China, Japan, South Korea, Australia.

Share on

APAC Tissue Diagnostics Market Research Report – Segmented by product type, disease, application, end-user, & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast | 2022 to 2027

Published: January, 2022

ID: 4093

Pages: 130

APAC Tissue Diagnostics Market Size (2022 to 2027)

The APAC tissue diagnostics market was worth USD 0.89 billion in 2022 and is estimated to be growing at a CAGR of 8.84%, to reach USD 1.36 billion by 2027.

Tissue-based diagnostic tests are performed to screen, diagnose, and monitor cancer patients' response to therapy. The tissue diagnostics market's scope includes major technologies like In Situ hybridization, IHC, digital pathology and workflow, special staining, and products such as instruments and consumables to determine medical information to diagnose diseases or conditions.

Tissue Diagnostics market expansion is expected to be driven by rising cancer prevalence, rising healthcare costs, and increased funding for research activities aimed at creating cancer treatments.

Other factors such as increased lifestyle changes, rising food and tobacco consumption, alcohol consumption, and an increase in prevalent lifestyle problems are expected to boost the market growth.

The tissue-based diagnosis method aids in determining the cause and effect of a patient's illness. The number of cancer incidents is increasing each year as a result of people's unhealthy lifestyles, boosting the demand for tissue-based diagnosis.

A cancer diagnosis and therapy at an early stage will increase the chances of survival. Therefore, the Diagnostics market will develop significantly as labs are forced to improve diagnosis efficiency to ensure patient health security.

The tissue diagnosis technique is one of the highest achievements in cancer diagnosis, and it is the market's most important driver.

On the other hand, the growing number of government programs raised awareness about the need for early cancer detection to propel the tissue Diagnostics market forward.

Furthermore, factors such as increased investments in research and development of new technologies, the emergence of efficient and accurate products, growing demand for personalized medicines, and untapped market potential due to a lack of efficient Diagnostics tests for non-small lung cancer detection are expected to provide lucrative opportunities for tissue Diagnostics market growth. Furthermore, the growing scale of healthcare institutes is expected to boost demand for the tissue diagnostics market.

However, The market growth is hampered by a small customer base for tissue Diagnostics, restricted budget constraints, and regulatory framework issues.

This research report on the APAC tissue diagnostics market has been segmented and sub-segmented into the following categories:

By Product Type:

Instruments
- Microscope
- Non-contact Handheld IR Thermometer
- Haemocytometer
- NMR Tube
- Others
Consumables
- Reagent kits
- Others

By Disease:

Lung cancer
Lymphoma
Pancreatic cancer
Breast cancer
Others

By Application:

Hematoxylin & Eosin
Immunohistochemistry
In Situ Hybridization

By End-user:

Hospitals
Diagnostic laboratories
Research Organizations
Contract Research Organizations
Biotechnology Companies

By Country:

India
China
Japan
South Korea
Australia
New Zealand
Thailand, Malaysia
Vietnam
Philippines
Indonesia
Singapore
Rest of APAC

The APAC tissue diagnostics market is anticipated to witness significant growth during the forecast period. The market growth is attributed to increased healthcare spending, growing infrastructure for cancer Diagnostics, and government assistance. Moreover, increased attention of government and private sectors in developing nations such as China. Japan, India, and other, the Asia Pacific market is expected to grow significantly during the forecast period. China, India, Japan, Korea, Indonesia, and Australia, according to the World Health Organization (WHO), are the primary regions with the highest number of cancer patients. As a result, Western medical devices companies are interested in expanding their operations in the Asia Pacific tissue Diagnostics market and medical devices business. Every year, an average of 70 million newly diagnosed patients are documented in the Asia Pacific region, according to the Cancer Index Organization. As the population of senior people grows, so does the risk of cancer, which means there is a lot of growth in the diagnosis market. The Southeast Asian countries are rapidly developing economically and investing heavily in the healthcare sector.

China accounted for the largest share of the Tissue Diagnostics market. The market growth is driven by the technological advancements in the healthcare sector, the presence of key market players, and favorable reimbursement policies.

On the other hand, the Indian Tissue Diagnostics market is one of the fastest-growing countries. The factors such as improving the rising healthcare sector, active, supportive government policies, and growing awareness are fuelling the market growth.

KEY MARKET PARTICIPANTS:

Some of the noteworthy companies dominating the APAC tissue diagnostics market are F. Hoffmann-La Roche AG, Sigma-Aldrich Co. LLC, Abbott Laboratories, Agilent Technologies, BioGenex, Danaher Corporation, Cell Signaling Technology, and Ventana Medical Systems.

1. Introduction

1.1 Market Definition

1.2 Study Deliverables

1.3 Base Currency, Base Year and Forecast Periods

1.4 General Study Assumptions

2. Research Methodology

2.1 Introduction

2.2 Research Phases

2.2.1 Secondary Research

2.2.2 Primary Research

2.2.3 Econometric Modelling

2.2.4 Expert Validation

2.3 Analysis Design

2.4 Study Timeline

3. Overview

3.1 Executive Summary

3.2 Key Inferences

3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

4.1 Market Drivers

4.2 Market Restraints

4.3 Key Challenges

4.4 Current Opportunities in the Market

5. Market Segmentation

5.1 Product type

5.1.1 Introduction

5.1.2 Instruments

5.1.2.1 Microscope

5.1.2.2 Non-contact Handheld IR Thermometer

5.1.2.3 Haemocytometer

5.1.2.4 NMR Tube

5.1.2.5 Others

5.1.3 Consumables

5.1.3.1 Reagent kits

5.1.3.2 Others

5.1.4 Y-o-Y Growth Analysis, By Product type

5.1.5 Market Attractiveness Analysis, By Product type

5.1.6 Market Share Analysis, By Product type

5.2 Disease

5.2.1 Introduction

5.2.2 Lung cancer

5.2.3 Lymphoma

5.2.4 Pancreatic cancer

5.2.5 Breast cancer

5.2.6 Others

5.2.7 Y-o-Y Growth Analysis, By Disease

5.2.8 Market Attractiveness Analysis, By Disease

5.2.9 Market Share Analysis, By Disease

5.3 Application

5.3.1 Introduction

5.3.2 Hematoxylin and Eosin

5.3.3 Immunohistochemistry

5.3.4 In Situ Hybridization

5.3.5 Y-o-Y Growth Analysis, By Application

5.3.6 Market Attractiveness Analysis, By Application

5.3.7 Market Share Analysis, By Application

5.4 End-user

5.4.1 Introduction

5.4.2 Hospitals

5.4.3 Diagnostic laboratories

5.4.4 Research Organizations

5.4.5 Contract Research Organizations

5.4.6 Biotechnology Companies

5.4.7 Y-o-Y Growth Analysis, By End-user

5.4.8 Market Attractiveness Analysis, By End-user

5.4.9 Market Share Analysis, By End-user

6. Geographical Analysis

6.1 Introduction

6.1.1 Regional Trends

6.1.2 Impact Analysis

6.1.3 Y-o-Y Growth Analysis

6.1.3.1 By Geographical Area

6.1.3.2 By Product type

6.1.3.3 By Disease

6.1.3.4 By Application

6.1.3.5 By End-user

6.1.4 Market Attractiveness Analysis

6.1.4.1 By Geographical Area

6.1.4.2 By Product type

6.1.4.3 By disease

6.1.4.4 By Application

6.1.4.5 By End-user

6.1.5 Market Share Analysis

6.1.5.1 By Geographical Area

6.1.5.2 By Product type

6.1.5.3 By Disease

6.1.5.4 By Application

6.1.5.5 By End-user

6.4 Asia-Pacific

6.3.1 Introduction

6.3.2 China

6.3.3 India

6.3.4 Japan

6.3.5 Australia

6.3.6 South Korea

7. Strategic Analysis

7.1 PESTLE analysis

7.1.1 Political

7.1.2 Economic

7.1.3 Social

7.1.4 Technological

7.1.5 Legal

7.1.6 Environmental

7.2 Porter’s Five analysis

7.2.1 Bargaining Power of Suppliers

7.2.2 Bargaining Power of Consumers

7.2.3 Threat of New Entrants

7.2.4 Threat of Substitute Products and Services

7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis

8.1 F. Hoffmann-La Roche AG

8.1.1 Overview

8.1.2 Product Analysis

8.1.3 Financial analysis

8.1.4 Recent Developments

8.1.5 SWOT analysis

8.1.6 Analyst View

8.2 Sigma-Aldrich Co. LLC

8.3 Abbott Laboratories

8.4 Agilent Technologies

8.5 BioGenex

8.6 Danaher Corporation

8.7 Cell Signaling Technology

8.8 Ventana Medical Systems

9. Competitive Landscape

9.1 Market share analysis

9.2 Merger and Acquisition Analysis

9.3 Agreements, collaborations, and Joint Ventures

9.4 New Product Launches

10. Market Outlook and Investment Opportunities

11. Appendix

a) List of Tables

b) List of Figures

Asia Pacific Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
Asia Pacific Instruments Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Consumables Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
Asia Pacific Lung cancer Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Lymphoma Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Pancreatic cancer Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Breast cancer Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Others Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
Asia Pacific Hematoxylin and Eosin Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Immunohistochemistry Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific In Situ Hybridization Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
Asia Pacific Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Diagnostic laboratories Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Research Organizations Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Contract Research Organizations Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Biotechnology Companies Market, By Region, From 2022 - 2027 (USD Billion)
Japan Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
Japan Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
Japan Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
Japan Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
China Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
China Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
China Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
China Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
India Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
India Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
India Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
India Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
Australia Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
Australia Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
Australia Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
Australia Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
South Korea Tissue diagnostics Market, By Product type, From 2022 - 2027 (USD Billion)
South Korea Tissue diagnostics Market, By Disease, From 2022 - 2027 (USD Billion)
South Korea Tissue diagnostics Market, By Application, From 2022 - 2027 (USD Billion)
South Korea Tissue diagnostics Market, By End user, From 2022 - 2027 (USD Billion)
Asia Pacific Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
Asia Pacific Microscope Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Non-contact Handheld IR Thermometer Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Haemocytometer Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific NMR Tube Market, By Region, From 2022 - 2027 (USD Billion)
Asia Pacific Others Market, By Region, From 2022 - 2027 (USD Billion)
Japan Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
China Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
India Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)
Australia Tissue diagnostics Market, By Instruments, From 2022 - 2027 (USD Billion)